BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19430886)

  • 1. Investigation of immunosuppressive mechanisms in a mouse glioma model.
    Ksendzovsky A; Feinstein D; Zengou R; Sharp A; Polak P; Lichtor T; Glick RP
    J Neurooncol; 2009 May; 93(1):107-14. PubMed ID: 19430886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
    Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
    Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.
    Cantini G; Pisati F; Mastropietro A; Frattini V; Iwakura Y; Finocchiaro G; Pellegatta S
    Cancer Immunol Immunother; 2011 Dec; 60(12):1739-50. PubMed ID: 21779877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.
    Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T
    Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
    Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
    Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
    Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
    Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
    J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.
    Panek WK; Pituch KC; Miska J; Kim JW; Rashidi A; Kanojia D; Lopez-Rosas A; Han Y; Yu D; Chang CL; Kane JR; Zhang P; Cordero A; Lesniak MS
    Mol Neurobiol; 2019 Jul; 56(7):5032-5040. PubMed ID: 30460615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.
    Sumitomo S; Fujio K; Okamura T; Morita K; Ishigaki K; Suzukawa K; Kanaya K; Kondo K; Yamasoba T; Furukawa A; Kitahara N; Shoda H; Shibuya M; Okamoto A; Yamamoto K
    J Immunol; 2013 Sep; 191(5):2351-9. PubMed ID: 23904169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
    Wu A; Wei J; Kong LY; Wang Y; Priebe W; Qiao W; Sawaya R; Heimberger AB
    Neuro Oncol; 2010 Nov; 12(11):1113-25. PubMed ID: 20667896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer.
    Liu XS; Lin XK; Mei Y; Ahmad S; Yan CX; Jin HL; Yu H; Chen C; Lin CZ; Yu JR
    Front Immunol; 2019; 10():1741. PubMed ID: 31417548
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
    Conroy H; Galvin KC; Higgins SC; Mills KH
    Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8.
    Edwards JP; Thornton AM; Shevach EM
    J Immunol; 2014 Sep; 193(6):2843-9. PubMed ID: 25127859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
    Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
    Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of regulatory T-cells in glioma immunology.
    Ooi YC; Tran P; Ung N; Thill K; Trang A; Fong BM; Nagasawa DT; Lim M; Yang I
    Clin Neurol Neurosurg; 2014 Apr; 119():125-32. PubMed ID: 24582432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines.
    Ueda R; Fujita M; Zhu X; Sasaki K; Kastenhuber ER; Kohanbash G; McDonald HA; Harper J; Lonning S; Okada H
    Clin Cancer Res; 2009 Nov; 15(21):6551-9. PubMed ID: 19861464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.